Hormonal contraceptives: all 330 studies that test it
Page 4 of 4. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular ReactivityStatus unknownNCT00439972Phase 2
- Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)CompletedNCT00403793Phase 2
- Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of MenorrhagiaCompletedNCT00393198Phase 4
- Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian FailureWithdrawnNCT00370019Phase 2
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended RegimenCompletedNCT00344383Phase 2
- An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional RegimenCompletedNCT00320580Phase 2
- The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia NervosaCompletedNCT00320567Phase 2
- Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling WomenCompletedNCT00319163Phase 1
- Estrogen Treatment in Acromegalic WomenStatus unknownNCT00315107Phase 2
- Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate PrognosisCompletedNCT00291369Phase 3
- Efficacy Trial of CDB 2914 for Emergency ContraceptionCompletedNCT00271583Phase 2/3
- PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvraCompletedNCT00269620Phase 4
- Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.CompletedNCT00261482Phase 4
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy FemalesCompletedNCT00254800Phase 1
- Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on OvulationCompletedNCT00254189Phase 2
- Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral ContraceptionCompletedNCT00248963Phase 3
- Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral ContraceptionCompletedNCT00245921Phase 3
- A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.CompletedNCT00236782Phase 3
- A Study of Efficacy and Safety With the Transdermal Contraceptive System.CompletedNCT00236769Phase 3
- NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone GelCompletedNCT00229593Phase 1
- Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric DisorderCompletedNCT00195559Phase 3
- Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal CombinationsCompletedNCT00184795Phase 3
- Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMSCompletedNCT00161681Phase 3
- Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric DisorderCompletedNCT00128934Phase 3
- Estrogen, HDL, and Coronary Heart Disease in WomenCompletedNCT00083824Phase 2/3
- Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor AntagonistCompletedNCT00044876Phase 2
- Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914CompletedNCT00041899Phase 1
- Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected WomenCompletedNCT00016601Not applicable
- Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of MenopauseCompletedNCT00009659Phase 2
- Safety of Estrogens in Lupus: Hormone Replacement TherapyTerminatedNCT00000419Phase 3